AI assistant
Sending…
PegBio Co., Ltd. — Earnings Release 2005
Dec 23, 2004
50676_rns_2004-12-23_152ef7d5-2d3d-40d4-8bfe-d8ab2af13700.htm
Earnings Release
Open in viewerOpens in your device viewer
Listed Company Information
| Listed Company Information |
| XIN CORP<01141> - Results Announcement Xin Corporation Limited announced on 23/12/2004: (stock code: 01141 ) Year end date: 31/03/2005 Currency: HKD Auditors' Report: N/A Interim report reviewed by: Audit Committee (Unaudited ) (Unaudited ) Last Current Corresponding Period Period from 01/04/2004 from 01/04/2003 to 30/09/2004 to 30/09/2003 Note ('000 ) ('000 ) Turnover : 83,758 11,862 Profit/(Loss) from Operations : (6,381) (12,102) Finance cost : (1,842) (3,295) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : (9,151) (15,397) % Change over Last Period : N/A % EPS/(LPS)-Basic (in dollars) : (0.008) (0.05) -Diluted (in dollars) : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : (9,151) (15,397) Interim Dividend : Nil Nil per Share (Specify if with other : N/A N/A options) B/C Dates for Interim Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: I. TURNOVER Turnover represents the net invoiced value of goods sold, after allowances for returns and trade discounts. II. LOSS FROM OPERATING ACTIVITIES The Group's loss from operating activities for the period is arrived at after charging: Six months ended 30 September 2004 2003 (Unaudited) (Unaudited) HK$'000 HK$'000 Depreciation 5,004 5,257 Staff costs 6,236 5,143 ======= ======= III. LOSS PER SHARE The calculation of basic loss per share is based on the unaudited consolidated net loss from ordinary activities attributable to shareholders for the six months ended 30 September 2004 of HK$9,151,000 (unaudited net loss for the six months ended 30 September 2003: HK$15,397,000) and the weighted average of 1,102,720,190 (2003: 335,812,912) ordinary shares of the Company in issue during the period. Diluted loss per share for the six months ended 30 September 2004 and 2003 have not been disclosed as the convertible note and bonds outstanding during the period had anti-dilutive effect on the basic loss per share for both periods. |
More from PegBio Co., Ltd.
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
Jun 3
Proxy Solicitation & Information Statement
2026
Jun 1
Proxy Solicitation & Information Statement
2026
Jun 1
Proxy Solicitation & Information Statement
2026
Jun 1
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 19
Board/Management Information
2026
May 19
Regulatory Filings
2026
May 6